This study will investigate the possible effects on rural access to treatment for opioid use disorder if Drug Enforcement Administration (DEA) waivers to prescribe buprenorphine as an office-based outpatient treatment for opioid addiction were available to Physician Assistants (PAs) and Nurse Practitioners (NPs). Better understanding of the potential additional workforce available to treat the devastating opioid use epidemic will allow policy makers to make informed decisions on expanding waiver eligibility.
|Andrilla CHA, Coulthard C, Larson EH, Patterson DG, Moore TE||Projected Contributions of Nurse Practitioners and Physicians Assistants to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas||PUBLICATION||08-09-2018||Article|
|Andrilla CHA, Moore TE, Patterson DG, Larson EH||Medication Assisted Treatment and the Rural Provider Workforce||PRESENTATION||03-27-2018|
|Andrilla CHA, Moore TE, Larson EH, Patterson DG||Projected contributions of nurse practitioners and physician assistants to buprenorphine treatment services for opioid use disorder in rural places||PRESENTATION||05-10-2018|